ArticleAnalytical chemistry2026
Assessing Surface Binding Events on Golgi Microsomes Isolated from Cancer Cells by Capillary Electrophoresis.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracellular membrane proteins represent a vast and pharmacologically essential class of therapeutic targets, yet their characterization within native pathological environments remains experimentally challenging. Here, we report what is, to the best of our knowledge, the first direct affinity measurements performed at the surface of Golgi microsomes isolated from cancer cells. By integrating affinity capillary electrophoresis (ACE) with a refined mathematical framework, we overcome long-standing obstacles associated with membrane protein analysis, including the need for target modification, intrinsic enzymatic activity, labeled probe, or large protein excess. The microfluidic format further minimizes sample consumption while enabling both direct and indirect detection modalities, thereby expanding applicability to impure compounds and ligands lacking charge or UV absorbance. Applying this strategy to UGCG, a Golgi-resident membrane protein of oncological relevance, we demonstrate quantitative ligand-binding measurements on fairly monodisperse vesicular fractions (∼150 nm) that preserve native intracellular architecture. Collectively, this work establishes a robust, broadly applicable platform for target engagement studies in complex biological systems and highlights the potential of ACE to accelerate drug discovery efforts involving intracellular or extracellular membrane-bound targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.